I'am very happy to have Medtronic show interest in endobarrier's progress,they are a big coy and they operate in the Diabetes space so they would have done their research here along with J&J. With Mondays candlestick displaying a long lower shadow we may have seen the bottom here, newsflow and the bank balance to back it up will support the rise from here.